A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2007 by Postgraduate Institute of Medical Education and Research.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Postgraduate Institute of Medical Education and Research
ClinicalTrials.gov Identifier:
NCT00430664
First received: February 1, 2007
Last updated: NA
Last verified: February 2007
History: No changes posted

February 1, 2007
February 1, 2007
January 2006
Not Provided
  • Success
  • Failure
Same as current
No Changes Posted
  • Death
  • Pain by VAS
  • Time to Pleurodesis
  • Others
Same as current
Not Provided
Not Provided
 
A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis
A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Pleurodesis is a technique used to fuse the two layers of the lining over the lung. This is done to get rid of collections of fluid or air in this space. A common reason would be cancer of the underlying lung or elsewhere causing fluid to collect in the pleural space. In this situation it is a palliative procedure to free the patient from symptoms like breathlessness.

Pleurodesis is a technique used to fuse the two layers of the pleura. This is done to prevent reaccumulation of collections of fluid or air in this space. Common indications are malignant pleural effusions, recurrent pneumothorax and even benign effusions which are otherwise difficult to eradicate.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Malignant Pleural Effusions
  • Recurrent Pleural Effusions
  • Primary Spontaneous Pneumothorax
  • Secondary Spontaneous Pneumothorax
Procedure: Pleurodesis with either talc or iodopovidone
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
100
December 2007
Not Provided

Inclusion Criteria:

  • Age over 12 years
  • Symptomatic recurrent pleural effusion
  • Pneumothorax needing pleurodesis

Exclusion Criteria:

  • Life expectancy <1 month
  • Unwilling to give consent
  • Empyema
  • ICTD drain output >150 ml/d
  • Presence of an airleak
Both
12 Years and older
No
India
 
NCT00430664
7134-PG-1Tg-05/5469-71
Not Provided
Not Provided
Postgraduate Institute of Medical Education and Research
Not Provided
Principal Investigator: Dheeraj Gupta, MD, DM, FCCP Additional Professor, Dept of Pulmonary Medicine, PGIMER, Chandigarh, India
Postgraduate Institute of Medical Education and Research
February 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP